Yuriko Uehara

Title: Yuriko Uehara: Innovator in Pharmaceutical Composition and Screening Systems

Introduction

Yuriko Uehara is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of pharmaceutical compositions and screening systems, particularly in relation to metabolic syndrome and blood glucose control. Her innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Uehara holds a patent titled "Method for screening a test substance for activating a receptor associated with FGF 21 activity." This invention utilizes betaKlotho or substances that modulate betaKlotho activity as agents for controlling FGF21 activity mediated by an FGF receptor. The pharmaceutical composition she developed is particularly aimed at treating or preventing metabolic syndrome and managing blood glucose levels. Furthermore, her invention includes a screening system designed to identify substances that enhance or suppress betaKlotho activity, utilizing a cell system that expresses an FGF receptor and/or betaKlotho on its surface. Uehara has 1 patent to her name.

Career Highlights

Yuriko Uehara is affiliated with the National Institute of Advanced Industrial Science and Technology, where she conducts her research and development. Her work is characterized by a strong focus on innovative solutions to complex health challenges, particularly in the realm of metabolic disorders.

Collaborations

Uehara collaborates with esteemed colleagues such as Masashi Suzuki and Toru Imamura. Their combined expertise contributes to the advancement of research in their respective fields.

Conclusion

Yuriko Uehara's contributions to pharmaceutical innovation and her pioneering patent reflect her commitment to improving health outcomes. Her work continues to inspire advancements in the treatment of metabolic syndrome and related conditions.